当前位置: X-MOL 学术Cancer Immunol. Res. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Remodeling Translation Primes CD8+ T-cell Antitumor Immunity.
Cancer Immunology Research ( IF 8.1 ) Pub Date : 2020-05-01 , DOI: 10.1158/2326-6066.cir-19-0516
Katie E Hurst 1, 2 , Kiley A Lawrence 1, 2 , Rob A Robino 1, 2 , Lauren E Ball 3 , Dongjun Chung 4, 5 , Jessica E Thaxton 1, 2, 5
Affiliation  

The requisites for protein translation in T cells are poorly understood and how translation shapes the antitumor efficacy of T cells is unknown. Here we demonstrated that IL15-conditioned T cells were primed by the metabolic energy sensor AMP-activated protein kinase to undergo diminished translation relative to effector T cells. However, we showed that IL15-conditioned T cells exhibited a remarkable capacity to enhance their protein translation in tumors, which effector T cells were unable to duplicate. Studying the modulation of translation for applications in cancer immunotherapy revealed that direct ex vivo pharmacologic inhibition of translation elongation primed robust T-cell antitumor immunity. Our work elucidates that altering protein translation in CD8+ T cells can shape their antitumor capability.

中文翻译:

重塑翻译引发 CD8+ T 细胞抗肿瘤免疫。

T 细胞中蛋白质翻译的必要条件知之甚少,翻译如何影响 T 细胞的抗肿瘤功效尚不清楚。在这里,我们证明了 IL15 条件 T 细胞由代谢能量传感器 AMP 激活的蛋白激酶引发,相对于效应 T 细胞而言,翻译减少。然而,我们发现 IL15 条件 T 细胞表现出显着的能力来增强其在肿瘤中的蛋白质翻译,而效应 T 细胞无法复制。研究在癌症免疫治疗中应用的翻译调节表明,直接体外药理学抑制翻译延伸可引发强大的 T 细胞抗肿瘤免疫。我们的工作阐明了改变 CD8+ T 细胞中的蛋白质翻译可以塑造它们的抗肿瘤能力。
更新日期:2020-05-01
down
wechat
bug